Product Information
PROPYLTHIOURACIL 50 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2814 per EA under NDC 00480924201. Its NADAC has been published 96 times since Aug 28, 2024.
Strength
50 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480924201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PROPYLTHIOURACILApproval Type
Generic (ANDA)
FDA Application
ANDA080172On Market Since
7/10/2024
Pharmacological Classes
Price Statistics
The NADAC for PROPYLTHIOURACIL 50 MG TABLET has been published 96 times since Aug 28, 2024, and over the history we have for it it has risen 15.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2814 per EA |
|---|---|
| All-time high | $0.3341 (Jul 16, 2025) |
| All-time low | $0.2433 (Nov 20, 2024) |
| 52-week high | $0.3341 |
| 52-week low | $0.2646 |
| Median price | $0.2831 |
| Average price | $0.2892 |
| Largest weekly change | +25.4% (Sep 18, 2024) |
| Weeks tracked | 96 |
| Tracking since | Aug 28, 2024 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PROPYLTHIOURACIL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PROPYLTHIOURACIL 50 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.2814 per EA (NDC 00480924201), effective Jun 24, 2026.
How has the price of PROPYLTHIOURACIL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for PROPYLTHIOURACIL 50 MG TABLET has risen 15.1%. It has been tracked across 96 weekly CMS publications since Aug 28, 2024.
What are the highest and lowest recorded NADAC prices for PROPYLTHIOURACIL 50 MG TABLET?
Since Aug 28, 2024, the NADAC for PROPYLTHIOURACIL 50 MG TABLET has ranged from a low of $0.2433 (Nov 20, 2024) to a high of $0.3341 (Jul 16, 2025), with a median of $0.2831 per EA.
Are there cheaper alternatives to PROPYLTHIOURACIL 50 MG TABLET?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PROPYLTHIOURACIL 50 MG TABLET, is $0.2724 per EA — about 3% below PROPYLTHIOURACIL 50 MG TABLET.
Who manufactures PROPYLTHIOURACIL 50 MG TABLET?
PROPYLTHIOURACIL 50 MG TABLET (NDC 00480924201) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification